Dipeptidyl peptidase 4 inhibitors

4214 2.5 Pill - yellow round, 8mm

Generic Name: saxagliptin

Pill with imprint 4214 2.5 is Yellow, Round and has been identified as Onglyza saxagliptin 2.5 mg. It is supplied by Bristol-Myers Squibb.

Onglyza is used in the treatment of Diabetes, Type 2 and belongs to the drug class dipeptidyl peptidase 4 inhibitors. There is no proven risk in humans during pregnancy. Onglyza saxagliptin 2.5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images

Onglyza (Saxagliptin [ sax-a-glip-tin ])-4214 2.5-saxagliptin 2.5 mg-Yellow-Round
Onglyza (Saxagliptin [ sax-a-glip-tin ])-4214 2.5-saxagliptin 2.5 mg-Yellow-Round
Onglyza (Saxagliptin [ sax-a-glip-tin ])-4214 2.5-saxagliptin 2.5 mg-Yellow-Round
Onglyza (Saxagliptin [ sax-a-glip-tin ])-4214 2.5-saxagliptin 2.5 mg-Yellow-Round
Onglyza (Saxagliptin [ sax-a-glip-tin ])-4214 2.5-saxagliptin 2.5 mg-Yellow-Round
Onglyza (Saxagliptin [ sax-a-glip-tin ])-4214 2.5-saxagliptin 2.5 mg-Yellow-Round

Onglyza
Generic Name: saxagliptin [ sax-a-glip-tin ]
Imprint: 4214 2.5
Strength: saxagliptin 2.5 mg
Color: Yellow
Size: 8.00 mm
Shape: Round
Availability: Prescription only
Drug Class: Dipeptidyl peptidase 4 inhibitors
Pregnancy Category: B - No proven risk in humans
CSA Schedule: Not a controlled drug
Labeler / Supplier: N/A
National Drug Code (NDC): N/A
Inactive Ingredients: Lactose monohydrate, Microcrystalline cellulose, Croscarmellose sodium, Magnesium stearate,
Latest News
Related Drugs